Share Share this content Opens in a new window Opens in a new window Opens in a new window Opens in a new window OPA's Submission to the Proposed Regs HSPTA You may be interested in The Policies Impacting Pharmacy October 29, 2020 Post category: Advocacy Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Advocacy Nirmatrelvir/Ritonavir (Paxlovid) Prescribing December 12, 2022 Post category: Advocacy Joint OPA NPAC Submission on COVID-19 Copayment Relief Proposal May 2, 2020 Post category: Advocacy
Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Advocacy
